An 12-week, Randomised, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg and Twice-daily Budesonide Giona Easyhaler 200 µg During Step-down in Well Controlled Asthma
Phase of Trial: Phase III
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Asthma
- Focus Therapeutic Use
- 12 Dec 2016 Status changed from recruiting to completed.
- 04 Apr 2016 New trial record
- 03 Apr 2016 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.